BALFX
Price
$40.43
Change
-$0.32 (-0.79%)
Updated
Jul 13 closing price
Net Assets
288.09B
ETNMX
Price
$15.48
Change
-$0.05 (-0.32%)
Updated
Jul 13 closing price
Net Assets
392.22M
Interact to see
Advertisement

BALFX vs ETNMX

BALFX vs ETNMX Comparison Chart in %
View a ticker or compare two or three
VS
BALFX vs. ETNMX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and ETNMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 288B vs. ETNMX (392M). ETNMX (1.76) and BALFX (1.75) have matching dividends . BALFX was incepted earlier than ETNMX: BALFX (25 years) vs ETNMX (11 years). ETNMX (1.02) is less costly to investors than BALFX (0.61). ETNMX is a more actively managed with annual turnover of: 55.00 vs. BALFX (50.00). BALFX has a lower initial minimum investment than ETNMX: BALFX (250) vs ETNMX (1000). BALFX annual gain was more profitable for investors over the last year : 12.01 vs. ETNMX (8.15). BALFX return over 5 years is better than : 32.95 vs. ETNMX (18.66).
BALFXETNMXBALFX / ETNMX
Total Expense Ratio0.611.0260%
Annual Report Gross Expense Ratio0.611.0260%
Fund Existence25 years11 years-
Gain YTD8.5339.97186%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B392M73,469%
Annual Yield % from dividends1.751.7699%
Returns for 1 year12.018.15147%
Returns for 3 years39.5530.61129%
Returns for 5 years32.9518.66177%
Returns for 10 years81.3481.22100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOH242.889.57
+4.10%
Molina Healthcare
SOPH5.720.07
+1.24%
SOPHiA GENETICS SA
GANX1.76-0.04
-2.22%
Gain Therapeutics
MLYS27.59-0.79
-2.78%
Mineralys Therapeutics
BJDX1.22-0.23
-15.86%
Bluejay Diagnostics Inc.